SENSIENT TECHNOLOGIES CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SENSIENT TECHNOLOGIES CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,421	1,396	1,387	1,323	1,332	1,380	1,437	1,456	1,557	1,612
Cost of revenue	908	887			908	926	948	996	1,050	1,073
Gross profit	513	510			424	455	489	460	507	539
Research and development	40.9	40.9	43	40.1	38.5	34.3	42.2	48.1	49.1	52.9
Selling, general and administrative	290	308	263	294	271	285	292	305	316	332
Operating income	186	168	203	121	153	170	197	155	192	207
Interest expense	18.3	19.4	21.9	20.1	14.8	12.5	14.5	25.2	28.8	29.6
Pre-tax income	167	148	182	101	138	157	182	130	163	178
Income tax	44.4	58.8	24.2	19	28.4	38.7	41.3	36.5	38.1	43.1
Income from continuing operations	123	89.6	157	82	109	119	141	93.4	125	134
Net income	126	89.6	157	82	109	119	141	93.4	125	134
EBITDA	233	216	257	176	202	222	249	213	252	268
EPS, basic	2.84	2.05	3.71	1.94	2.59	2.82	3.36	2.22	2.96	3.18
EPS, diluted	2.82	2.03	3.70	1.94	2.59	2.81	3.34	2.21	2.94	3.16
Shares, basic (weighted)	44.5	43.8	42.4	42.3	42.3	42.1	41.9	42	42.1	42.2
Shares, diluted (weighted)	44.8	44	42.5	42.3	42.3	42.3	42.2	42.2	42.4	42.6
Dividend per share	1.11	1.23	1.35	1.47	1.56	1.58	1.64	1.64	1.64	1.64

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	25.9	29.3	31.9	21.2	24.8	25.7	20.9	28.9	26.6	36.5
Receivables	195	195	255	213	234	261	302	272	290	305
Inventory	404	464	491	423	381	412	564	598	600	678
Other current assets	51	43.2	44.9	40	48.6	42.7	47.6	37.1	44.9	59.7
Total current assets	717	733	823	788	742	741	935	937	962	1,081
Property, plant and equipment	477	499	491	437	445	446	483	505	492	539
Lease right-of-use assets					23.3	26.5	36.3	36.3	36.4	39.9
Goodwill	384	409	416	407	423	420	416	424	412	440
Intangible assets	8.13	7.21	18.9	11.8	10.9	15	18.6	12.1	11.9	10.1
Other non-current assets	70.5	68.3	66.8	80.9	89.9	93	96.6	94.9	96.3	102
Total assets	1,668	1,724	1,825	1,740	1,741	1,745	1,982	2,015	2,024	2,244
Accounts payable	92.5	110	132	94.7	107	126	142	131	139	138
Accrued liabilities	26.5	23.6	23.4	18.7	2.2	0.8	43.7	26.4	47.5	44
Short-term debt	20.6	20.1	20	0	8.89	8.54	20.4	13.5	19.8	0.35
Total current liabilities	214	216	215	201	216	232	272	236	271	264
Long-term debt	583	604	690	598	518	503	630	645	614	709
Lease liabilities				9.9	17.5	20.6	28	28	28.7	29.2
Other non-current liabilities	6.1	13.5	8.55	17.8	30.2	28.8	37.2	37.8	39.5	40.1
Total liabilities	832	872	965	859	807	807	982	961	963	1,051
Total debt	583	604	690	599	527	503	631	645	614	709
Paid-in capital	108	107	102	98.4	103	111	124	116	118	124
Retained earnings	1,379	1,414	1,516	1,536	1,579	1,631	1,703	1,727	1,782	1,847
Treasury stock	-443	-525	-598	-595	-594	-634	-632	-623	-617	-612
Other comprehensive income	-213	-149	-166	-163	-159	-175	-201	-172	-227	-170
Shareholders' equity	836	852	860	882	934	938	1,000	1,053	1,061	1,194
Total equity	836	852	860	882	934	938	1,000	1,053	1,061	1,194
Total liabilities and equity	1,668	1,724	1,825	1,740	1,741	1,745	1,982	2,015	2,024	2,244

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	126	89.6	157	82	109	119	141	93.4	125	134
Depreciation and amortization	47	48.5	53.2	55	49.6	52.1	52.5	57.8	60.3	61.1
Stock-based compensation	7.71	5.86	0.5	-0.74	5.61	9.57	16.1	8.93	10.1	13.9
Deferred income tax	10.4	17.4	9.84	-19.3	-8.71	-6.07	-11	-5.1	-18.6	-2.71
Change in receivables	-4.27	-131	-96.6	10.9	-11.4	-34.6	-46.1	35.8	-29.6	-1.11
Change in inventory	-20.1	-47.3	-34.1	25.2	46.8	-36.3	-159	-28.2	-18.3	-62.2
Cash from operations	184	36.3	83.5	177	219	145	12.1	170	157	128
Capital expenditures	-81.2	-56.3	-50.7	-39.1	-52.2	-60.8	-79.3	-87.9	-59.2	-89.4
Acquisitions	0	0	-31.1	0	0	-13.9	-22.7	-1.65	0	-4.87
Cash from investing	-36.4	110	14.8	-37.4	-33.4	-35.6	-98.4	-87.6	-59.2	-92.7
Debt issued	223	231	323	47.1	36.7	112	329	352	159	216
Debt repaid	-247	-240	-284	-134	-154	-110	-171	-355	-167	-178
Stock issued	0.7	0.3	0.1
Share buybacks	-50.1	-87.2	-76.7	0	0	-42.5	0	0
Dividends paid	-49.6	-54	-57.4	-62.2	-66.1	-66.7	-68.9	-69.2	-69.4	-69.6
Cash from financing	-128	-153	-98.7	-151	-184	-108	86.2	-82	-81.5	-35
Exchange rate effect	-5.44	10.2	2.93	0.06	2.41	-0.93
Net change in cash	13.9	3.48	2.56	-10.7	3.62	0.97	-4.82	8.01	-2.31	9.91
Free cash flow	102	-20	32.8	138	167	84.4	-67.3	81.8	97.9	38.4
Interest paid	18.5	19.5	21.6	20.1	14.8	12.6	14.7	24.4	29.1	29.4
Income taxes paid	29.2	29.3	24.1	40.1	44.8	29.2	48.2	39.7	56.7	48.8

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $129.22 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	34.6%	Gross profit / revenue.
Operating margin	14.0%	Operating income / revenue.
EBITDA margin	17.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	12.2%	Pre-tax income / revenue.
Net margin	9.3%	Net income / revenue.
FCF margin	0.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	7.2%	Cash from operations / revenue.
Effective tax rate	24.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	12.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.7%	Net income / average total assets.
Return on invested capital (ROIC)	9.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	20.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	7.0%	Capital expenditures / revenue.
D&A / revenue	3.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	3.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	6.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	3.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	8.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	1.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	6.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	2.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	5.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	7.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-1.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	4.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	7.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-1.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	4.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-18.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	119.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-10.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-60.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-25.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	1.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	6.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	4.39x	Current assets / current liabilities.
Quick ratio	1.51x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.12x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.61x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	32.2%	Total debt / total assets.
Liabilities / assets	46.9%	Total liabilities / total assets.
Net debt	$732.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.43x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	7.74x	Operating income / interest expense.
Working capital	$914.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	18.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$815.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.72x	Revenue / average total assets.
Fixed asset turnover	2.96x	Revenue / average property, plant and equipment.
Inventory turnover	1.55x	Cost of revenue / average inventory.
Days inventory	236 days	365 x average inventory / cost of revenue.
Receivables turnover	4.52x	Revenue / average receivables.
Days sales outstanding	81 days	365 x average receivables / revenue.
Days payables	48 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	269 days	Days inventory + days sales outstanding - days payables.
FCF conversion	2.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	96.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.69	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$39.84	Revenue / diluted weighted shares.
FCF per share	$0.10	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.89	Cash from operations / diluted weighted shares.
Book value per share	$29.47	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$19.07	Tangible book value / shares outstanding.
Cash per share	$0.73	(Cash + short-term investments) / shares outstanding.
Payout ratio	44.2%	Dividends paid / net income, when net income is positive.
Dividends / FCF	1,557.0%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.50B	Share price x shares outstanding.
Enterprise value	$6.23B	Market cap + total debt - cash - short-term investments.
P/E	34.8x	Market cap / net income. Only when net income is positive.
P/S	3.23x	Market cap / revenue.
P/B	4.37x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	6.75x	Market cap / tangible book value, when positive.
P/FCF	1,227x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	44.6x	Market cap / cash from operations, when positive.
EV/Sales	3.66x	Enterprise value / revenue.
EV/EBIT	26.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	20.7x	Enterprise value / EBITDA, when both are positive.
EV/FCF	1,391x	Enterprise value / free cash flow, when both are positive.
FCF yield	0.1%	Free cash flow / market cap.
Earnings yield	2.9%	Net income / market cap (the inverse of P/E).
Dividend yield	1.3%	Dividends paid over the period / market cap.
Shareholder yield	1.3%	(Dividends paid + share buybacks) / market cap.

What was SENSIENT TECHNOLOGIES CORP's revenue in fiscal 2025?

SENSIENT TECHNOLOGIES CORP reported revenue of $1.61B for fiscal 2025, 3.5% higher than the year before.

Was SENSIENT TECHNOLOGIES CORP profitable in fiscal 2025?

Yes. Net income was $134.5M, a net margin of 8.3%.

How much free cash flow did SENSIENT TECHNOLOGIES CORP generate in fiscal 2025?

Cash from operations of $127.8M minus capital expenditures of $89.4M left free cash flow of $38.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SENSIENT TECHNOLOGIES CORP